NCLEX Review Guide: Sulfonamides - Urinary & Renal Pharmacology

Mechanism of Action & Classification

• Sulfonamides are bacteriostatic antibiotics that inhibit bacterial synthesis of folic acid by competing with para-aminobenzoic acid (PABA). They prevent bacterial DNA synthesis and reproduction rather than directly killing bacteria.
• Common sulfonamides include sulfamethoxazole-trimethoprim (Bactrim, Septra) and sulfisoxazole, primarily used for urinary tract infections and some systemic infections.

Primary Uses

• Urinary tract infections (UTIs) caused by E. coli, Klebsiella, and Proteus species are the most common indication. Sulfonamides concentrate in urine, making them highly effective for UTI treatment.
• Pneumocystis jirovecii pneumonia (PCP) prevention and treatment in immunocompromised patients, particularly those with HIV/AIDS.
• Some skin and soft tissue infections, traveler's diarrhea, and as prophylaxis for certain surgical procedures.

Assessment & Monitoring

1. Assess for sulfa allergy history before administration - cross-sensitivity exists with other sulfa-containing medications
2. Monitor complete blood count (CBC) for bone marrow suppression including thrombocytopenia, leukopenia, and anemia
3. Evaluate renal function through BUN, creatinine, and urinalysis as sulfonamides can cause crystalluria and kidney damage
4. Assess skin integrity and monitor for Stevens-Johnson syndrome - a life-threatening skin reaction

Common & Serious Adverse Effects

• Allergic reactions ranging from mild rash to severe anaphylaxis and Stevens-Johnson syndrome occur in 3-5% of patients. Cross-reactivity exists with other sulfonamide medications.
• Crystalluria and kidney stones can develop due to precipitation of sulfonamide crystals in acidic urine, potentially leading to acute kidney injury.
• Hematologic effects include thrombocytopenia, hemolytic anemia, and agranulocytosis, requiring regular CBC monitoring during prolonged therapy.
• Photosensitivity reactions cause increased sunburn risk, requiring sun protection education for patients.

Essential Teaching Points

• Maintain adequate fluid intake (2-3 liters daily unless contraindicated) to prevent crystalluria and promote drug elimination through the kidneys.
• Take medication with food to reduce GI upset, and complete the entire prescribed course even if symptoms improve to prevent bacterial resistance.
• Report any skin rash, fever, or unusual bleeding immediately as these may indicate serious adverse reactions requiring immediate medical attention.
• Use sunscreen and protective clothing as sulfonamides increase photosensitivity and risk of severe sunburn.